Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives Camila Pepe Ribeiro de Souza, MsC, Natália Bolzachini Santoni, BsC, Thais Gomes de Melo, MsC, Marcio Jansen de Oliveira Figueiredo, PhD, Francisco Carlos da Costa Darrieux, PhD, Leopoldo Soares Piegas, PhD, Sheila Ouriques Martins, PhD Value in Health Regional Issues Volume 8, Pages 36-42 (December 2015) DOI: 10.1016/j.vhri.2015.02.003 Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Fig. 1 Markov model structure. Value in Health Regional Issues 2015 8, 36-42DOI: (10.1016/j.vhri.2015.02.003) Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions